PreveCeutical Medical Inc. (OTCMKTS:PRVCF) Sees Large Decline in Short Interest

PreveCeutical Medical Inc. (OTCMKTS:PRVCF) was the target of a significant drop in short interest in February. As of February 15th, there was short interest totalling 21,300 shares, a drop of 61.3% from the January 31st total of 55,000 shares. Based on an average daily trading volume, of 154,800 shares, the days-to-cover ratio is currently 0.1 days.

PreveCeutical Medical Stock Down 4.7 %

PreveCeutical Medical stock traded down $0.00 during midday trading on Friday, reaching $0.02. The stock had a trading volume of 7,000 shares, compared to its average volume of 156,182. The firm’s fifty day simple moving average is $0.02 and its 200-day simple moving average is $0.02. PreveCeutical Medical has a 1-year low of $0.01 and a 1-year high of $0.03.

PreveCeutical Medical Company Profile

PreveCeutical Medical Inc, a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and obesity.